KR840005454A - 세푸록심 에스테르의 제조방법 - Google Patents

세푸록심 에스테르의 제조방법 Download PDF

Info

Publication number
KR840005454A
KR840005454A KR1019830003535A KR830003535A KR840005454A KR 840005454 A KR840005454 A KR 840005454A KR 1019830003535 A KR1019830003535 A KR 1019830003535A KR 830003535 A KR830003535 A KR 830003535A KR 840005454 A KR840005454 A KR 840005454A
Authority
KR
South Korea
Prior art keywords
solution
product
recovered
process according
cefucec
Prior art date
Application number
KR1019830003535A
Other languages
English (en)
Other versions
KR910000046B1 (ko
Inventor
가드프레이 엘리오트(외 3) 레오나드
Original Assignee
베리 안토니 뉴삼
글락소 그룹 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10532012&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR840005454(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 베리 안토니 뉴삼, 글락소 그룹 리미티드 filed Critical 베리 안토니 뉴삼
Publication of KR840005454A publication Critical patent/KR840005454A/ko
Application granted granted Critical
Publication of KR910000046B1 publication Critical patent/KR910000046B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

세푸륵심 에스테르의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 본 발명에 따르는, 고도로 순수하며 실질적으로 무정형인 세푸륵심 악세틸의 적외선 스펙트럼.
제2도는 본 발명에 따르는, 고도로 순수하며 실질적으로 무형적인 세푸륵심 악세틸의 n.m.r.스펙트럼.

Claims (13)

  1. 세푸륵심 악세틸의 용액으로 부터, 고도로 순수하며 실질적으로 무정형인 생성물이 스득되는 조건하에서 세푸륵심 악세틸을 회수함을 특징으로 하여, 고도로 순수하며 실질적으로 무정형인 세푸륵심 악세틸을 제조하는 방법.
  2. 제1항에 있어서, 생성물이 5% m/m미만의 불순물을 함유하는 방법.
  3. 제1항 또는 2항에 있어서, 생성물이 결정성물질을 실질적으로 함유하지 않는 방법.
  4. 제1항 내지 3항중의 어느하나에 있어서, 용액이 케톤, 알콜, 아세토니트릴, 테트라하이드로푸란, 디옥산, 에스테르, 염소화용매, 전술한 용매중 적어도 2가지의 균질한 혼합물 및 전술한 용매중의 적어도 하나와 물의 균질한 혼합물 중에서 선택된 유기 용매를 함유하는 방법.
  5. 제1항 내지 4항중의 어느하나에 있어서, 회수하기 전에 용액중의 에스테르 농도가 적어도 1%m/m인 방법.
  6. 제1항 내지 4항중의 어느하나에 있어서, 회수하기 전에 용액중의 에스테르 농도가 적어도 10%m/m인 방법.
  7. 제1항 내지 6항중의 어느 하나에 있어서, 생성물이 R 및 S이성체의 혼합물이며 S이성체에 대한 R에성체의 비율이 0.9:1 내지 1.1:1인 방법.
  8. 제1항 내지 7항중의 어느 하나에 있어서, 분무 건조방법에 의해 회수하는 방법.
  9. 제8항에 있어서, 분무건조를 불활성 건조가스 존재하에서 수행하는 방법.
  10. 제8항 또는 9항에 있어서, 생성물이 일정한 범위의 입자크기를 가지며 유공성 소구형인 방법.
  11. 제1항 내지 7항중의 어느 하나에 있어서, 로울러 건조 방법에 의해 회수하는 방법.
  12. 제1항 내지 7항중의 어느 하나에 있어서, 용매침전 방법에 의해 회수하는 방법.
  13. 제1항 내지 7항중의 어느 하나에 있어서, 동결 건조방법에 의해 회수하는 방법.
    참고사항 : 최초출원 내용에 의하여 공개하는 것임.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830003535A 1982-07-30 1983-07-29 무정형 세푸록심 에스테르의 제조방법 KR910000046B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB22019 1982-07-30
GB8222019 1982-07-30
GB8222019 1982-07-30

Publications (2)

Publication Number Publication Date
KR840005454A true KR840005454A (ko) 1984-11-12
KR910000046B1 KR910000046B1 (ko) 1991-01-19

Family

ID=10532012

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830003535A KR910000046B1 (ko) 1982-07-30 1983-07-29 무정형 세푸록심 에스테르의 제조방법

Country Status (41)

Country Link
US (4) US4562181A (ko)
EP (1) EP0107276B1 (ko)
JP (1) JPH0730084B2 (ko)
KR (1) KR910000046B1 (ko)
AT (1) AT382154B (ko)
AU (1) AU566881B2 (ko)
BE (1) BE897422A (ko)
CA (1) CA1240313A (ko)
CH (1) CH657134A5 (ko)
CS (1) CS259515B2 (ko)
CY (1) CY1434A (ko)
CZ (1) CZ280528B6 (ko)
DE (2) DE3374010D1 (ko)
DK (2) DK164507C (ko)
DO (1) DOP1990004773A (ko)
EC (1) ECSP941098A (ko)
ES (1) ES524590A0 (ko)
FI (1) FI76093C (ko)
FR (1) FR2531087B1 (ko)
GB (1) GB2127401B (ko)
GR (1) GR79349B (ko)
HK (1) HK84288A (ko)
HU (1) HU190603B (ko)
IE (1) IE55748B1 (ko)
IL (1) IL69375A (ko)
IT (1) IT1168206B (ko)
KE (1) KE3805A (ko)
LU (1) LU84935A1 (ko)
MY (1) MY8700058A (ko)
NL (1) NL8302705A (ko)
NO (1) NO163897C (ko)
NZ (1) NZ205083A (ko)
PL (1) PL156001B1 (ko)
PT (1) PT77135B (ko)
SE (1) SE453195B (ko)
SG (1) SG26088G (ko)
SK (1) SK403191A3 (ko)
SU (1) SU1266471A3 (ko)
YU (1) YU44680B (ko)
ZA (1) ZA835579B (ko)
ZW (1) ZW17383A1 (ko)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
JPS5953175A (ja) * 1982-09-22 1984-03-27 淵脇　豊弘 自動部品供給装置
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US5017380A (en) * 1986-07-02 1991-05-21 Shionogi & Co., Ltd. Gelatin hard capsule containing crystalline hydrate of oral cephalosporin
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
CA1339136C (en) * 1987-07-01 1997-07-29 Sailesh Amilal Varia Amorphous form of aztreonam
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
IT1230095B (it) * 1989-04-27 1991-10-05 Parenta Srl Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici.
AT393955B (de) * 1990-03-30 1992-01-10 Martin Dr Leixnering Einrichtung zur nachbehandlung frischer beugesehnenverletzungen
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
NZ299077A (en) * 1996-07-26 1998-06-26 Apotex Inc Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf
IT1289955B1 (it) * 1997-02-21 1998-10-19 Solchem Italiana Spa Acyclovir sale sodico biidrato e sua preparazione
KR100187959B1 (ko) * 1997-03-31 1999-06-01 윤재승 저융점 무정형 세푸록심 악세틸의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (ko) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
GB9726781D0 (en) * 1997-12-19 1998-02-18 Glaxo Group Ltd Pharmaceutical composition
PT937727E (pt) * 1998-02-20 2002-07-31 Fako Ilaclari A S Processo para a producao de cefuroxima azetil cristalina soluvel
KR100299356B1 (ko) * 1998-03-03 2001-10-27 윤재승 수분흡수에대해안정한세푸록심악세틸함유제약조성물
JP2002505290A (ja) * 1998-03-03 2002-02-19 ダエウン ファーマシューティカル カンパニー リミテッド 水分吸収に対して安定であるセフロキシムアクセチルを含む医薬組成物
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
US6384213B1 (en) 1998-10-23 2002-05-07 Ranbaxy Laboratories Limited Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
KR100363566B1 (ko) * 1998-11-20 2003-08-19 국제약품공업주식회사 무정형 세푸록심 악세틸의 제조방법
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ES2202069T3 (es) 1999-03-19 2004-04-01 Ranbaxy Laboratories, Ltd. Procedimiento para la preparacion de una forma de dosificacion oral biodisponible de axetil cefuroxima.
IN191236B (ko) 1999-05-25 2003-10-11 Ranbaxy Lab Ltd
IN191492B (ko) * 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
US6930983B2 (en) * 2000-03-15 2005-08-16 Texas Instruments Incorporated Integrated circuits, systems, apparatus, packets and processes utilizing path diversity for media over packet applications
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
IN191496B (ko) * 1999-07-30 2003-12-06 Ranbaxy Lab Ltd
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
KR100357816B1 (ko) * 2000-05-09 2002-10-18 보령제약 주식회사 무정형 세푸록심 악세틸의 제조 및 이의 분리방법
IN190849B (ko) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
KR20020016052A (ko) * 2000-08-24 2002-03-04 최현식 무정형 세푸록심 악세틸의 제조방법
AT411996B (de) * 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
KR100399195B1 (ko) * 2001-03-17 2003-09-26 신풍제약주식회사 무정형 세푸록심 악세틸의 제조방법
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011766A1 (it) * 2001-08-10 2003-02-10 A & G Soluzioni Digitali S R L Dispositivo e metodo per la simulazione della presenza di una o piu' sorgenti di suoni in posizioni virtuali nello spazio acustico a tre dim
JP4105091B2 (ja) * 2001-09-10 2008-06-18 エフ．ホフマン−ラ ロシュ アーゲー 油性チキソトロープ性配合物
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
CZ12993U1 (cs) * 2001-11-23 2003-02-10 Glaxo Group Limited Farmaceutický prostředek
US7034162B2 (en) * 2002-08-12 2006-04-25 Dr. Reddy's Laboratories Limited Amorphous form of 3-[2-(dimethylamino) ethyl]-N-methyl-1H-indole-5-methane sulfonamide succinate (sumatriptan succinate)
US6911441B2 (en) * 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20070054953A1 (en) * 2003-05-12 2007-03-08 Potluri Ramesh B A novel process for preparation of indole derivatives
US20050079213A1 (en) * 2003-06-06 2005-04-14 Unilab Pharmatech Ltd Pharmaceutical compositions
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
US7633033B2 (en) * 2004-01-09 2009-12-15 General Lasertronics Corporation Color sensing for laser decoating
US20090175952A1 (en) * 2004-01-09 2009-07-09 Jong Soo Woo Cefuroxime axetil granule and process for the preparation thereof
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
WO2007063552A1 (en) * 2005-12-02 2007-06-07 Lupin Limited Stable taste masked formulations of cephalosporins
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
SE529796C2 (sv) * 2006-02-08 2007-11-27 Optoskand Ab Fiberoptiskt kontaktdon
US10112257B1 (en) 2010-07-09 2018-10-30 General Lasertronics Corporation Coating ablating apparatus with coating removal detection
EP2741750A1 (en) 2011-08-12 2014-06-18 Dhanuka Laboratories Ltd. Pharmaceutical composition comprising cefuroxime
US9895771B2 (en) 2012-02-28 2018-02-20 General Lasertronics Corporation Laser ablation for the environmentally beneficial removal of surface coatings
WO2013151516A1 (en) 2012-04-04 2013-10-10 Mahmut Bilgic Film tablet formulations comprising cefuroxime axetil and clavulanic acid
US10086597B2 (en) 2014-01-21 2018-10-02 General Lasertronics Corporation Laser film debonding method
CN105131016A (zh) * 2015-08-04 2015-12-09 江苏正大清江制药有限公司 一种头孢呋辛酯的制备方法
CN116284050B (zh) * 2022-12-19 2024-04-12 华北制药河北华民药业有限责任公司 一种高效率结晶型头孢呋辛酯转无定型粉体的方法及产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
US4002748A (en) * 1976-01-19 1977-01-11 Eli Lilly And Company Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1572993A (en) * 1976-02-16 1980-08-13 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
IT1162665B (it) * 1978-09-21 1987-04-01 Glaxo Group Ltd Procedimento per ppeparare cefalosporine
JPS5562714A (en) * 1978-11-01 1980-05-12 Hitachi Ltd Garnet film for magnetic bubble
AT367424B (de) * 1979-04-06 1982-07-12 Glaxo Group Ltd Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
US4444686A (en) * 1982-01-25 1984-04-24 Pfizer Inc. Crystalline penicillin ester intermediate
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile

Also Published As

Publication number Publication date
DK349083D0 (da) 1983-07-29
YU155883A (en) 1986-04-30
US4994567A (en) 1991-02-19
AU566881B2 (en) 1987-11-05
DE3374010D1 (en) 1987-11-12
DE3327449A1 (de) 1984-02-02
NO832773L (no) 1984-01-31
US4562181A (en) 1985-12-31
IL69375A (en) 1986-12-31
CS568783A2 (en) 1988-03-15
IE55748B1 (en) 1991-01-02
ATA276783A (de) 1986-06-15
FI76093B (fi) 1988-05-31
CA1240313A (en) 1988-08-09
ES8505689A1 (es) 1985-06-01
KR910000046B1 (ko) 1991-01-19
CS259515B2 (en) 1988-10-14
CY1434A (en) 1988-09-02
DK68392A (da) 1992-05-25
SG26088G (en) 1988-07-15
JPH0730084B2 (ja) 1995-04-05
YU44680B (en) 1990-12-31
AU1741783A (en) 1984-02-02
EP0107276A2 (en) 1984-05-02
LU84935A1 (fr) 1983-11-23
US4820833A (en) 1989-04-11
NL8302705A (nl) 1984-02-16
SE453195B (sv) 1988-01-18
IE831804L (en) 1984-01-30
DOP1990004773A (es) 1999-02-09
SK277896B6 (en) 1995-07-11
CZ403191A3 (en) 1993-05-12
KE3805A (en) 1988-06-03
ZW17383A1 (en) 1983-10-26
AT382154B (de) 1987-01-26
HU190603B (en) 1986-09-29
FR2531087A1 (fr) 1984-02-03
DK68392D0 (da) 1992-05-25
FI76093C (fi) 1988-09-09
DK164507C (da) 1992-11-23
NO163897B (no) 1990-04-30
DK349083A (da) 1984-01-31
IT1168206B (it) 1987-05-20
NZ205083A (en) 1986-03-14
PT77135B (en) 1986-01-24
GB2127401A (en) 1984-04-11
JPS5944391A (ja) 1984-03-12
ECSP941098A (es) 1995-01-16
SK403191A3 (en) 1995-07-11
PL243228A1 (en) 1984-08-27
IT8348789A0 (it) 1983-07-29
FR2531087B1 (fr) 1985-11-22
GB2127401B (en) 1986-04-16
EP0107276A3 (en) 1985-03-06
SE8304208D0 (sv) 1983-07-29
IL69375A0 (en) 1983-11-30
PL156001B1 (pl) 1992-01-31
ES524590A0 (es) 1985-06-01
GB8320518D0 (en) 1983-09-01
CH657134A5 (de) 1986-08-15
CZ280528B6 (cs) 1996-02-14
PT77135A (en) 1983-08-01
GR79349B (ko) 1984-10-22
EP0107276B1 (en) 1987-10-07
BE897422A (fr) 1984-01-30
NO163897C (no) 1990-08-08
US5013833A (en) 1991-05-07
HK84288A (en) 1988-10-28
MY8700058A (en) 1987-12-31
DK164507B (da) 1992-07-06
SU1266471A3 (ru) 1986-10-23
FI832757A (fi) 1984-01-31
ZA835579B (en) 1984-09-26
FI832757A0 (fi) 1983-07-29
SE8304208L (sv) 1984-01-31

Similar Documents

Publication Publication Date Title
KR840005454A (ko) 세푸록심 에스테르의 제조방법
DE69909279D1 (de) Transxanthophyllesterkonzenrate von erhöhter reinheit und verfahren zu deren herstellung
JPS53131989A (en) Molecular sieving organic gas removing agent
GB1417810A (en) Method of recovering maleic anhydride
KR920008194A (ko) 테이코플라닌 회수 방법
GB1527788A (en) Process for the production of finely divided solid cyanuric chloride
ES8503388A1 (es) Procedimiento para la recuperacion de disolventes en la limpieza de generos textiles
KR950016568A (ko) 스테비아 감미료의 정제방법
JPS5377002A (en) Purification of isoprene
KR880005169A (ko) 에폭시수지의 제조방법
JPS5545641A (en) Alkali metal-tetracyanoquinodimethane crown compound complex
JPS52145499A (en) Method for removing impurities from polyphenylene ether
JPS534346A (en) Process for treating organic sludge
JPS5214739A (en) Process for recovery of terephthalic acid
KR930005952A (ko) 이소플루란의 제조 방법
KR840005821A (ko) 프로필렌 중합체의 정제 방법
SU608763A1 (ru) Способ получени очищенного бикарбоната натри
GB650781A (en) Process for purification of solvents
JPS52151184A (en) Preparation of benzo (c) cinnoline and its derivatives
GEP19991789B (en) Process for Removing Metoxy-Aromatic Impurities from Naturally Occuring Cresylic Acid Mixtures, Process for Removing Guaiacols from Naturally Occuring Cresylic Acid Mixtures
SE8103228L (sv) Forfarande for separering av vattenhaltiga blandningar innehallande organiska losningsmedel
SU1659398A1 (ru) Способ рекуперации этилацетата или метилэтилкетона из паровоздушной смеси
JPS53144543A (en) Improved method of producing cylcohexane derivative
SU519394A1 (ru) Способ очистки хлористого водорода
JPS5235799A (en) Recovery method for zeolite

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J206 Request for trial to confirm the scope of a patent right
J801 Dismissal of trial

Free format text: REJECTION OF TRIAL FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 19971002

Effective date: 19980918

FPAY Annual fee payment

Payment date: 20030107

Year of fee payment: 13

EXPY Expiration of term